Carrot announced that it partnered with Oura and Dexcom to deliver actionable, personalized insights supporting fertility goals. The companies came together to provide actionable, personalized insights through the metabolic-fertility program, Sprints. This collaboration combines Carrot’s clinical expertise with advanced insights from Oura, a leading smart wearable ring maker, and Dexcom, a leading continuous glucose monitor […]
Dexcom
The top CGM stories of 2025
Millions of people worldwide are looking for ways to manage their diabetes. That’s where the continuous glucose monitor (CGM) comes in. The CGM market is expected to experience substantial, double-digit percentage growth over the next five years, reaching nearly $29 billion by 2030. Market leaders Abbott and Dexcom continue to establish their hold on the […]
12 things you need to know about the CGM market
The CGM market is an exciting, fast-growing, multibillion-dollar sector for the medical device industry, according to our latest Medtech Market Intelligence Report for MassDevice. The report on the CGM market — available for purchase on MassDevice — draws on numerous sources, including but not limited to: medical associations, government data, medical journals, leading medtech publications, clinical […]
Dexcom leadership addresses G7 issue claims, hopes for expanded CGM coverage
Amid some scrutiny over its latest-generation G7 continuous glucose monitor (CGM), Dexcom (Nasdaq:DXCM) officials addressed claims on the company’s latest earnings call. A recent class action lawsuit brought G7 into the spotlight, demanding a jury trial for claims that Dexcom’s representations for G7 were false, misleading, and deceptive to consumers. The lawsuit says G7 places […]
CGM market report: Significant growth is ahead
As millions of people worldwide seek ways to manage their diabetes, the continuous glucose monitor (CGM) market continues to grow rapidly. Medtech market analysts project significant growth for the market over the next five years. Chrystal Larsen, a veteran medtech market analyst, produced a detailed report for MassDevice outlining the future of the CGM market. The report covers […]
Dexcom stock is down after hours despite Q3 beats, raised sales guidance
Dexcom (Nasdaq:DXCM) shares took a hit after hours today on third-quarter results that came in ahead of the consensus forecast. Shares of DXCM fell more than 8% to $62.69 apiece after the market closed today. The San Diego-based continuous glucose monitor (CGM) maker reported profits of $283.8 million. That equals 70¢ per share on sales […]
Dexcom adds Stanford Medicine chair to its board of directors
Dexcom (Nasdaq:DXCM) announced today that it appointed Dr. Euan Ashley to its board of directors, effective Oct. 24, 2025. Ashley, a renowned researcher, entrepreneur and clinician, brings extensive leadership experience across healthcare research institutions and private organizations. He currently serves as chair of the Dept. of Medicine at Stanford Health. Research areas for Ashley span […]
Dexcom is facing a class action suit related to G7 CGM
A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of California. The lawsuit, led by plaintiff Kelly Grisoli on behalf of all others similarly situated, demands a jury trial for claims that Dexcom’s representations for its latest-generation G7 continuous glucose monitor (CGM) were false, misleading, […]
Dexcom CEO takes temporary leave of absence
Dexcom (Nasdaq:DXCM) today filed an SEC form to announce that Chair and CEO Kevin Sayer is taking a temporary medical leave of absence. Sayer’s leave went into effect on Sept. 14, 2025. The Dexcom board appointed Jake Leach to serve as interim principal executive officer, in addition to his current duties as president and COO. Leach […]
Dexcom to unveil new basal insulin titration module under FDA review, reports positive CGM data
Dexcom (Nasdaq:DXCM) today announced plans to unveil its Smart Basal integrated titration module for insulin delivery. The company plans to unveil Smart Basal and present new continuous glucose monitor (CGM) data at the 61st annual European Association for the Study of Diabetes (EASD) Conference in Vienna, Austria, this week. Dexcom’s CTO Girish Naganathan will speak […]
